1971
DOI: 10.1093/ajcp/56.3.394
|View full text |Cite
|
Sign up to set email alerts
|

Pulmonary Adiaspiromycosis in Man Caused byEmmonsia crescens: Report of a Unique Case

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
7
0
1

Year Published

1974
1974
2018
2018

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(10 citation statements)
references
References 0 publications
2
7
0
1
Order By: Relevance
“…However, it is uncertain if antifungal treatment accelerated recovery or if this was merely the natural history of the infection. Patients appeared to benefit from corticosteroids in three previous cases (cases 4 and 21 from Table 1 and a case described in reference 29), and in the case described herein as well; this intervention seems reasonable in the immunocompetent patient because the major pathogenic effect of the fungus is due to the host granulomatous response. In severe pulmonary adiaspiromycosis in the immunocompetent host, it is reasonable to give both antifungal treatment to destroy the organism that provokes the inflammation and corticosteroid treatment to modulate that response.…”
Section: Fromsupporting
confidence: 52%
See 1 more Smart Citation
“…However, it is uncertain if antifungal treatment accelerated recovery or if this was merely the natural history of the infection. Patients appeared to benefit from corticosteroids in three previous cases (cases 4 and 21 from Table 1 and a case described in reference 29), and in the case described herein as well; this intervention seems reasonable in the immunocompetent patient because the major pathogenic effect of the fungus is due to the host granulomatous response. In severe pulmonary adiaspiromycosis in the immunocompetent host, it is reasonable to give both antifungal treatment to destroy the organism that provokes the inflammation and corticosteroid treatment to modulate that response.…”
Section: Fromsupporting
confidence: 52%
“…The first human case of Emmonsia, presenting as a solitary pulmonary nodule, was reported in 1964 (14). Disseminated human pulmonary disease was first observed in 1971 (29). Approximately 67 probable cases of human pulmonary adiaspiromycosis due to E. crescens have been described in the literature.…”
Section: Resultsmentioning
confidence: 99%
“…cescens or var.parvum, which are characterized by their incapacity to multiply in host tissues; instead, the conidia increase in size and form large round bodies called adiaconidia [1-3, 6, 12]. Most of the cases published in the literature indicate that the pathological lesions occur more frequently in the lungs [1,4,5,8,13,14,18, 19]. Reports dealing with extrapulmonary lesions or disseminated lung disease are rare [7,[9][10][11][15][16][17].…”
mentioning
confidence: 99%
“…It is a common fungal infection of lower order mammals, most usually wild rodents, with wide geographical distribution. This disease is caused by a geophilic fungus, Emmonsia parva var crescens 14 18 , whose dustb o r n e m y c e l i a l p h a s e ( c o n i d i a ) m a y b e accidentally inhaled and produce a perifocal granulomatous inflammatory reaction in the lungs 14 . In immunocompetent patients, fungus dissemination to extra pulmonary sites has not been reported 8 10 11 17 19 .…”
mentioning
confidence: 99%